Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
358 studies found for:    leukemia [CONDITION] AND child [AGE-GROUP] | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
leukemia [CONDITION] AND child [AGE-GROUP] | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
Condition: Leukemia
Intervention: Drug: Ara-c
2 Recruiting Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL
Condition: Leukemia
Interventions: Drug: Amsacrine;   Drug: Clofarabine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin hydrochloride;   Drug: Dexamethasone;   Drug: Doxorubicin hydrochloride;   Drug: Etoposide phosphate;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Pegaspargase;   Drug: Thioguanine;   Drug: Vincristine sulfate;   Radiation: Whole-brain radiation therapy
3 Recruiting International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010
Condition: Acute Lymphoblastic Leukemia (ALL)
Interventions: Drug: SR-A + Epratuzumab;   Drug: SR-B + Epratuzumab
4 Recruiting Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HR First Relapse B-precursor ALL
Condition: Leukemia, Acute Lymphoblastic
Interventions: Drug: Blinatumomab;   Drug: Conventional Consolidation Chemotherapy
5 Recruiting International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
Condition: Acute Myeloid Leukaemia
Interventions: Drug: Gemtuzumab ozogamicin;   Drug: Liposomal daunorubicin;   Drug: Mitoxantrone;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Busulfan;   Drug: Cyclophosphamide
6 Recruiting Prevalence of Psychocognitive Impairments in Adolescents Surviving Childhood Leukemia : LEA-PsyCog
Condition: Adolescents Surviving Childhood Leukemia LEA
Intervention: Other: neuropsychological evaluation
7 Recruiting Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML
Condition: Leukemia, Myeloid, Acute
Intervention: Drug: G-CSF
8 Recruiting Study of Blood Samples From Newborns With Down Syndrome
Condition: Leukemia
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: pharmacological study
9 Recruiting Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Condition: Leukemia
Interventions: Drug: Bortezomib;   Drug: Pravastatin
10 Recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: ITMHA;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Pegaspargase;   Drug: Asparaginase Erwinia Chrysanthemi;   Drug: Bortezomib;   Drug: Vorinostat;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Leucovorin Calcium;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Vincristine
11 Recruiting The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: 6-mercaptopurine, Methotrexate;   Drug: 6-mercaptopurine, Methotrexate, Vincristine, Dexamethasone
12 Recruiting Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: ATRA;   Drug: ATRA + IDA
13 Recruiting Epigenetic Reprogramming in Relapse AML
Condition: Leukemia, Acute Myeloid
Interventions: Drug: Decitabine;   Drug: Vorinostat;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim;   Drug: Sorafenib
14 Not yet recruiting Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML
Condition: Acute Myeloid Leukemia
Interventions: Drug: Idarubicin;   Drug: Cytarabine;   Drug: Cyclophosphamide;   Drug: Physician-Directed Regimens without Cyclophosphamide
15 Recruiting Azacytidine Plus FLAG for Relapsed or Refractory AML
Condition: Acute Myeloid Leukemia
Interventions: Drug: Azacytidine;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim
16 Recruiting Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
Condition: Acute Myeloid Leukemia
Intervention: Drug: Interferon-alpha
17 Not yet recruiting Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant
Condition: Acute Myeloid Leukemia in Children
Interventions: Procedure: CIML NK Cell Infusion;   Procedure: CD3+ T Cell Product Infusion;   Procedure: Peripheral blood draw
18 Recruiting Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
Condition: Acute Lymphoblastic Leukemia (ALL)
Interventions: Drug: Prednisolone;   Drug: Dexamethasone;   Drug: L-Asparaginase;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Daunorubicin;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: 6-Mercaptopurine;   Drug: Thioguanine;   Drug: Fludarabine;   Drug: Imatinib
19 Recruiting Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation
Condition: Leukemia
Intervention: Other: DLI of the 20 fraction of the UCBT
20 Recruiting Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies
Conditions: B-Cell Leukemia;   B-Cell Lymphoma
Interventions: Biological: 4SCAR19/22 T cells;   Drug: Interleukin-2

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.